Doximity, which ranks fifth on the IBD 50, crushed December-quarter expectations late Thursday and raised its outlook for the ...
Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.
14h
Investor's Business Daily on MSNKemper Stock Gets IBD Rating UpgradeThis unique rating measures technical performance by showing how a stock's price movement over the last 52 weeks compares to ...
15h
The Brighterside of News on MSNKeto diet improves multiple sclerosis, IBD and arthritis symptomsDiet plays a pivotal role in influencing autoimmune diseases like multiple sclerosis (MS), inflammatory bowel disease, and ...
Mozart Therapeutics, the leading developer of CD8 Treg network modulators in autoimmune disease, announces the presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results